Now live: Innocentive Marketplace. Get shortlisted for funded opportunities today.
Innovation Showcase

Novartis

At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues.

View our latest Challenges

Novartis is reimagining medicine to improve and extend people’s lives.

As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.

Why are we here?

At Novartis, we use science-based innovation to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Our Open Innovation mission is to deliver transformative innovation. In our pursuit of transformative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life.

What Challenge will you solve today?

Join Novartis Oncology at the latest medical congresses

Learn how Novartis is pushing the boundaries with bold science, seeking to transform lives and striving toward cures for patients.

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.

Visit Novartis to learn more

Innovating for challenging healthcare issues

Data and Digital

Embedding data science and digital technologies across Novartis to transform the way we innovate in R&D, run our business operations and engage with HCPs and patients.

Read more

Cell & Gene Therapy at Novartis

Our teams aim to deliver on the promise of cell and gene therapy for patients.

Read more

Patients & Caregivers

We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Read more

Healthcare Professionals

We work closely with healthcare professionals around the world to understand their unmet needs and create innovative programs to support their work.

Read more

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world.

Industry

Pharmaceuticals

Headquarters

Switzerland

Total Challenges Run

5

Visit the Challenge Homepage to view all open Challenges

New to Innocentive? Learn more about Challenges and how to Become a Solver

How does the Challenge process work?

Follow these steps to participate in Innocentive challenges and potentially win awards.

1

Register as a Solver

To register for a Solver account and join Innocentive:

  • Go to the Innocentive Challenge Center registration page.
  • Enter an email address, which will be used to login to your account.
  • Complete the remaining required fields including: (1) Name, (2) Display Name and (3) Location.
  • Create a password. You will be guided to ensure you create a strong password to protect your account.
  • Click the Register button.
  • After you complete the registration form, you will receive an email notification confirming your registration and containing instructions to activate your account.
  • Click the link in the email. You will be asked to accept the Innocentive Terms of Use to complete the account activation process.
2

Review the Challenge Agreement

The Challenge Agreement (formerly Challenge Specific Agreement or CSA) is a legal document that outlines a Solver's rights and responsibilities if they elect to submit a solution in response to an Innocentive Challenge. The Challenge Agreement specifies if and how IP will be transferred between Solver and Seeker; it may also specify any special rules, such as exclusionary rules for categories of Solvers, that apply to the Challenge.

You must accept the Challenge Agreement to be able to submit a solution to the Challenge. Be sure to read and understand the Challenge Agreement for each Challenge because you will be subject to the applicable Challenge conditions.

Challenge Agreements provide Solvers with clear details around participation, legal IP transfer (if applicable), and details around Prize and Scouting Challenges.

3

Submit a Solution

To submit a Solution to an Innocentive Challenge as a member of the Solver community:

  1. Go to the Innocentive Challenge Center.
  2. Select a Challenge.
  3. Click Register Interest & Accept Agreement.
  4. Agree to the Challenge Agreement.
  5. Click Add Solution.
  6. Enter any required information.
  7. Attach your solution files.
  8. Click Publish.

You will receive an email confirmation of receipt of your solution to your registered email address.

4

Win

Receive cash awards or collaboration agreements if your solution or proposal is accepted by Seeker organizations.

Your solution will be evaluated following the due date for submissions. You will then be notified via email as to whether your solution has been successful. In some challenges, you will also receive feedback on your submission.

Award Potential

We've awarded more than $60 million to thousands of Solvers from around the world.

The average award amount is approximately $20,000, but some challenges come with awards of over $100,000 or collaboration agreements.